The effect of Myrtoid suppository in hemerrhoid treatment
Phase 3
- Conditions
- hemorrhoids.Unspecified haemorrhoids without complication
- Registration Number
- IRCT201506211165N7
- Lead Sponsor
- Baghiatallah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
All the visited patients with hemorrhoid symptoms who lack the exclusion criteria
Exclusion criteria:
External thrombosed hemorrhoid; Internal strangulated hemorrhoid; Anal fistula; Anal fissure; Anal abscess; Pregnancy; Portal hypertension; Type 3 and 4 hemorrhoids; Renal insufficiency; Malignancies
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Bleeding. Timepoint: Before intervention, 2 weeks after the initial intervention. Method of measurement: questionnaire.;Pain during bowel movements. Timepoint: Before intervention, 2 weeks after the initial intervention. Method of measurement: questionnaire.;Constant pain in anus. Timepoint: Before intervention, 2 weeks after the initial intervention. Method of measurement: questionnaire.;Heaviness in anus. Timepoint: Before intervention, 2 weeks after the initial intervention. Method of measurement: questionnaire.;Tenesmus. Timepoint: Before intervention, 2 weeks after the initial intervention. Method of measurement: questionnaire.;Anal itching. Timepoint: Before intervention, 2 weeks after the initial intervention. Method of measurement: questionnaire.;Irritation in anus. Timepoint: Before intervention, 2 weeks after the initial intervention. Method of measurement: questionnaire.
- Secondary Outcome Measures
Name Time Method Adverse effects. Timepoint: during the treatment period. Method of measurement: clinical assessment.